CagriSema is Novo Nordisk's fixed-dose combination of cagrilintide and semaglutide
It is worth approaching your doctor to see if this is the cause of some of your symptoms and if you would be considered a good candidate to receive vitamin B12 injections
2.1% (consistent with weight loss rate) No Safety Signals: No increased risk of pancreatitis, thyroid tumors, or major CV events Historic Achievement: REDEFINE-1 demonstrated that CagriSema produces the highest mean weight loss (22.7%) ever reported for an obesity pharmacotherapy in a Phase 3 trial
That's also where diabetic peripheral neuropathy adds another layer of complexity impaired circulation and nerve signaling make the already-limited healing environment in foot tissue even harder to overcome without targeted support
Kong YX, Li ZS, Liu YB, Pan B, Fu X, Xiao R, et al